Serotonin type 3–receptor antagonists for chemotherapy-induced nausea and vomiting: Therapeutically equivalent or meaningfully different?

Ítems similars

• The serotonin type 3 receptor antagonist BRL 43694 and nausea and vomiting induced by cisplatin.
  per: Carmichael, J., et al.
  Publicat: (1988)
• Evolving role of neurokinin 1-receptor antagonists for chemotherapy-induced nausea and vomiting
  per: Navari RM, et al.
  Publicat: (2018-10-01)
• Evolving role of neurokinin 1-receptor antagonists for chemotherapy-induced nausea and vomiting
  per: Navari, Rudolph M, et al.
  Publicat: (2018)
• Casopitant: a novel NK(1)-receptor antagonist in the prevention of chemotherapy-induced nausea and vomiting
  per: Ruhlmann, Christina, et al.
  Publicat: (2009)
• The impact of 5-hydroxytryptamine-receptor antagonists on chemotherapy treatment adherence, treatment delay, and nausea and vomiting
  per: Palli, Swetha Rao, et al.
  Publicat: (2015)